tiprankstipranks
Trending News
More News >
Acrux Limited (AU:ACR)
:ACR
Advertisement

Acrux (ACR) Price & Analysis

Compare
3 Followers

ACR Stock Chart & Stats


Acrux News

ACR FAQ

What was Acrux Limited’s price range in the past 12 months?
Acrux Limited lowest share price was AU$0.01 and its highest was AU$0.07 in the past 12 months.
    What is Acrux Limited’s market cap?
    Acrux Limited’s market cap is AU$6.14M.
      When is Acrux Limited’s upcoming earnings report date?
      Acrux Limited’s upcoming earnings report date is Aug 22, 2025 which is 7 days ago.
        How were Acrux Limited’s earnings last quarter?
        Acrux Limited released its earnings results on Feb 25, 2025. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
          Is Acrux Limited overvalued?
          According to Wall Street analysts Acrux Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Acrux Limited pay dividends?
            Acrux Limited pays a Annually dividend of AU$0.06 which represents an annual dividend yield of N/A. See more information on Acrux Limited dividends here
              What is Acrux Limited’s EPS estimate?
              Acrux Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Acrux Limited have?
              Acrux Limited has 409,263,520 shares outstanding.
                What happened to Acrux Limited’s price movement after its last earnings report?
                Acrux Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.667%.
                  Which hedge fund is a major shareholder of Acrux Limited?
                  Currently, no hedge funds are holding shares in AU:ACR

                  Company Description

                  Acrux Limited

                  Acrux (ACR) is an Australian pharmaceutical company that specializes in the development and commercialization of innovative topical drug delivery systems. It operates primarily in the healthcare and biotechnology sectors, focusing on creating products that provide alternative delivery methods for drugs, particularly through the skin. Acrux is known for its patented technology which has been utilized in therapeutics for hormone replacement and pain management.

                  Acrux (ACR) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Living Cell Technologies
                  Invex Therapeutics Ltd.
                  Chimeric Therapeutics Ltd.
                  Neuroscientific Biopharmaceuticals Ltd.
                  Memphasys Ltd

                  Ownership Overview

                  4.88%95.12%
                  Mutual Funds
                  ― Other Institutional Investors
                  95.12% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis